Perrigo Corp (PRGO) - Koefisien utang jangka dawa marang modal

Perrigo Corp - logo grafis emiten PRGO

Perrigo Company plc (PRGO) dominates the OTC segment, leveraging a pipeline of affordable generics and an extensive retail network to drive margin growth. This price chart confirms its status as a reliable B2B partner producing medications for the largest pharmacy brands. The indicator stands at 1.33, underscoring the resilience of a closed private label ecosystem protected from external players by stringent FDA requirements.

Perrigo Company PLC (PRGO): Utang jangka dawa marang ekuitas saka 04.07.2022 nganti 29.10.2026
Produk mawa merek Perrigo Company plc

This indicator measures the proportion of long-term liabilities within the equity structure, determining the degree of financial leverage and the company's resilience to long-term credit risks. For Perrigo Company plc (PRGO), the regionalization of raw material supply chains requires capital expenditures; therefore, analyzing the ratio of long-term loans to equity allows for an assessment of how effectively the company finances its logistical transformation without risking default.

Analisis perusahaan pesaing

Haleon PLC - Kewajiban jangka dawa marang ekuitas|Utang jangka dawa marang modal KVUE|VRNA (Verona Pharma Inc.) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal MENS (Jyong Biotech Ltd)|Utang jangka dawa marang modal ligand.com LGND|AMRX - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal ALVO (Alvotech S.A.)|Liquidia Technologies (LQDA) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang ekuitas Galapagos Corp|ANIP (ANI Pharmaceuticals) - Utang jangka dawa marang modal|Utang jangka dawa marang modal mannkindcorp.com|Rasio utang jangka dawa marang ekuitas AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Pharmaceuticals) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas ARS Pharma SPRY|Theravance Corp (TBPH) - Kewajiban jangka dawa marang modal|AQST: Rasio utang jangka dawa marang ekuitas|scPharmaceuticals Inc. - Rasio silihan jangka dawa marang modal|TECX: Utang jangka dawa marang modal|Tonix Pharma - Koefisien utang jangka dawa marang modal|SXTC (SXT Pharmaceuticals) - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Eupraxia Pharma EPRX|Utang jangka dawa marang ekuitas BioHarvest Sciences (BHST)|EXOZ (invizyne.com) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Oramed Pharmaceuticals Inc. ORMP|ENTX (Entera Bio Ltd) - Kewajiban jangka dawa marang ekuitas|MindWalk - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal ABVC BioPharma, Inc|Cumberland Pharmaceuticals (CPIX) - Utang jangka dawa marang ekuitas|quantumbiopharma.com - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas FibroGen|TELO: Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal RANI|Rasio tanggungan utang jangka dawa marang modal synergychc.com|Utang jangka dawa marang modal RLYB (Rallybio)|Tanggungan utang jangka dawa marang ekuitas Lexaria Bioscience Corp|PULM - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang modal Pheton Holdings Ltd|APM (aptorumgroup.com) - Rasio utang jangka dawa marang ekuitas|Lyra Therapeutics Inc - Koefisien utang jangka dawa marang modal|IBO (Impact BioMedical Inc) - Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas TNF Pharma (TNFA)|Utang jangka dawa marang ekuitas cbdMD, Inc. (YCBD)|PRFX - Kewajiban jangka dawa marang modal|Utang jangka dawa marang ekuitas Altamira Therapeutics Ltd. CYTO|LIPO - Rasio utang jangka dawa marang ekuitas|OPTN - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang ekuitas PIRS|PROC: Utang jangka dawa marang modal|Petros Pharmaceuticals Inc (PTPI) - Utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Qilian International Holding Group Limited|Rasio utang jangka dawa marang modal SLRN (ACELYRIN Inc.)|Rasio utang jangka dawa marang ekuitas TFFP (TFF Pharmaceuticals)